2020-11-13,"   《HKEx》- 01952 EVEREST MED-B - Monthly Return of Equity Issuer on Movements in Securities for the month ended December 31, 2020 "
2020-10-09,   《HKEx》- 01952 EVEREST MED-B - VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON APPROVAL OF CLINICAL TRIAL APPLICATION BY CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR PHASE 3 REGISTRATION TRIAL OF SACITUZUMAB GOVITECAN-HZIY FOR METASTATIC UROTHELIAL CANCER 
2020-10-09,   《HKEx》- 01952 EVEREST MED-B - VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON SUBMISSION OF NEW DRUG APPLICATION IN SINGAPORE FOR SACITUZUMAB GOVITECAN-HZIY FOR THE TREATMENT OF METASTATIC TRIPLE-NEGATIVE BREAST CANCER 
2020-10-09,   《HKEx》- 01952 EVEREST MED-B - LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS 
